Financing ·
Quoin Pharmaceuticals enters ATM sales agreement with Leerink Partners to sell ADSs
QNRXQuoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd. entered into a sales agreement with Leerink Partners LLC on November 4, 2026, authorizing the company to sell American Depositary Shares (ADSs) from time to time through an at-the-market offering. Each ADS represents 35 ordinary shares. The agent is entitled to compensation of 3.0% of gross sale proceeds. Either party may terminate or suspend the agreement upon notice. Quoin Pharmaceuticals Ltd. operates in the biopharmaceutical industry, focusing on drug discovery and development.